Mental health (MH) impacts physical health. In comparison with the general population, people with MH and substance use conditions have a greater level of exposure to risk factors that contribute to a range of chronic physical health conditions, leading to higher mortality and lower life expectancy.
Full article available to subscribers
Mental health (MH) impacts physical health. In comparison with the general population, people with MH and substance use conditions have a greater level of exposure to risk factors that contribute to a range of chronic physical health conditions, leading to higher mortality and lower life expectancy.1–3 This relationship between mental and physical health represents a significant element of the personal, social and economic impact of MH conditions for people throughout their lives.4
International evidence has shown that a more positive patient experience of healthcare can improve health, clinical, financial, service and satisfaction outcomes.5 For people with MH and substance use conditions, several aspects of quality of care may contribute to inequitable outcomes. These include structural and financial barriers to accessing services, and prejudice and discrimination from health professionals (whether implicit or overt) that can lead to over-looked or misattributed physical symptoms, missed or late diagnoses and limited access to the best treatment options.6 High-quality primary care has been shown to improve health outcomes and wellbeing of people with MH conditions;7 however, studies conducted overseas show that people with MH conditions often report low levels of satisfaction with their primary healthcare experience.8–10
Te Tāhū Hauora (the New Zealand Health Quality & Safety Commission [HQSC]) has been running patient experience surveys for nearly a decade in Aotearoa New Zealand. The survey programme provides tools and data to support national and local monitoring and quality improvement initiatives. The adult primary care patient experience survey (PCPES) was the source of data for this study,11 which samples people who have had a recent visit to a general practice.
The objective of this study was to compare the primary healthcare experiences of adult patients with and without long-term MH conditions (those lasting or expected to last for more than 6 months), using data from the PCPES. The main research question was: “Does the reported experience of primary health care differ in survey respondents with a self-reported MH condition compared to those without?” It was not possible to separately assess patient experience for people with substance use conditions due to the absence of relevant survey questions. Information on clinician-reported MH diagnoses was also not available.
The HQSC PCPES data are collected on a quarterly basis. Every 3 months, a sample of adults aged 15 years and over who are enrolled with and have been seen by a general practice within Aotearoa New Zealand is invited to complete an online survey. Each participating practice prepares a list of all eligible patients who have had a consultation with the practice over a designated 1–2-week period. Eligible patients with contact details are invited by email to complete an online survey. Extra efforts are made to reach Māori and Pacific patients by sending an SMS reminder 2 days after the initial email invitation. The overall response rate is 16–17%.11
We analysed PCPES responses in the 2-year period from quarter 3 of 2020 to quarter 2 of 2022 (August 2020 to May 2022). The survey asked respondents about experiences at the most recent interaction with a healthcare professional in primary care.
The survey question “Which, if any, of the following long-term health conditions have you been diagnosed with and currently have?” was used to classify respondents into those with and without MH conditions. A long-term health condition was defined in the survey as “a physical or mental illness or condition that has lasted, or is expected to last, for more than six months. The symptoms may come and go or be present all the time.” Where this question had not been answered, responses were excluded from analysis.
The “with MH condition(s)” group comprised responses from people reporting a diagnosis of at least one of “Anxiety”, “Depression” or “Other MH conditions”, and the “without MH condition(s)” group captured all remaining responses, including those who reported not currently having any long-term health conditions.
Characteristics of each of the two groups were compared, stratified as follows:
Seven experience of care questions were grouped into three dimensions of care outlined below:
Relationships:
Barriers to care:
Meeting needs:
Demographic and other descriptive characteristics are presented for the two groups using frequency counts and proportions. The number of other long-term health conditions reported by respondents was determined and frequency counts were reported for any conditions that represented over 10% of all responses for either group.
For experience of care measures, we reported the count and proportion of responses within each group that reported “yes definitely”, “somewhat” and “no” to each question. Respondents that did not include an answer to a specific question were excluded from analysis relating to that question. Eight of the nine questions were framed so that a positive report of experience was indicated by “yes definitely”, except for the question “Were you unable to get an appointment with a GP/nurse sometime in past year?”, where a positive experience was indicated by “no”. Response options for this question were limited to “yes” and “no”. Comparisons focussed on the most positive responses (“yes definitely” and “no” respectively) in order to focus on the group reporting the best care experiences (as the aim of health services). However, all three levels of response are reported.
Comparative analysis of the experience of care measures was completed to contrast experiences reported by those with and without a MH condition. Results were further stratified by ethnicity (Māori/non-Māori), age group and gender.
Age/gender-standardised estimates of the proportions of responses to each question were developed for the groups with and without MH conditions, with 95% confidence intervals, following principles for age-standardisation of complex survey estimates.12 Firstly, estimates of responses for each question were produced accounting for survey weights for each group (those with/without MH conditions), further stratified by age and gender. The age–gender standardisation step then involved creating reference weights reflecting the relative distribution of age and gender among PCPES respondents with MH conditions: these weights were then applied to the sample-weighted estimates stratified by group and age/gender to produce standardised estimates by group. Similarly, to compare experiences reported by Māori and non-Māori with and without MH conditions, age/gender-standardised estimates were developed that matched the age/gender structure of the MH conditions group. That is, to consider differences between groups without confounding by age or gender, the group with MH conditions was used as the standard population for standardisation.
For each analysis, risk differences were calculated from the standardised estimates to compare the proportions of the most positive responses from each group of survey questions. The risk difference (also called the absolute risk reduction) measures the difference observed for the outcome of interest between two groups, when accounting for a differential age/gender profile by group, providing an estimated difference in experiencing an event.13
During the study period, there were 229,083 survey responses. Of these, 27,433 had not answered the long-term conditions question, leaving a total sample of 201,650 eligible responses.
About one in five (21%) of eligible survey respondents reported a current diagnosed MH condition, with the majority reporting anxiety (67%) and/or depression (59%) (Table 1). Survey respondents who reported not having a MH condition were more likely to be older, male and non-Māori than those with a MH condition.
View Table 1–3, Figure 1.
Both groups presented with a substantial burden of chronic disease, reflecting a population of people attending primary care. Two-thirds of all respondents indicated they had at least one long-term physical health condition (not including MH conditions). For respondents with one or more MH condition, 14.7% reported having three or more long-term physical health conditions, compared with 11.7% of those with no MH conditions. People with MH conditions were less likely to report high blood pressure and more likely to report long-term pain conditions and asthma than those without MH conditions, in keeping with the age and gender distribution of people with MH conditions in our sample.
Most respondents in both groups had seen a doctor at their recent visit—82% of respondents without MH conditions and 85% of those with MH conditions. Smaller proportions reported having seen a nurse—17% without MH conditions and 13% with MH conditions, respectively. Only 1% of respondents with MH conditions indicated they had seen a MH professional at their most recent primary care visit.
While most respondents reported positive experiences of primary healthcare, we found a pattern of worse experiences for those with MH conditions reflected consistently across dimensions of care experience.
Those without MH conditions reported more positive experiences than those with MH conditions (Figure 1) across all but one experience of care measure (whether MH needs were met) after adjusting for age and gender differences between groups.
Standardised comparisons and risk differences are provided in Table 2. Within the “relationships” dimension of care, being treated with respect received the highest proportions of positive responses for both groups (95.8% without and 94.5% with MH conditions), with no significant difference between the groups. This was closely followed by being listened to (93.1% and 90.9% respectively), which also showed the widest difference between groups (risk difference [RD] = -2.2%) and the only significant difference between groups within this dimension of care.
Differences between groups were more marked across measures in the “barriers to care” dimension, particularly regarding the ability of respondents to access primary care consultations. Respondents with MH conditions were more likely to report problems with obtaining an appointment with a general practitioner (GP) or nurse during the past year than those without MH conditions (RD=7.1%). Respondents with MH conditions were also less likely to report that primary care providers spend enough time with them (RD=-3.2%).
Within the “meeting needs” dimension of care, respondents with MH conditions were less likely to report that their individual needs had been met (RD=-3.6%). Respondents with MH conditions were much more likely to report having their MH needs met at the most recent appointment (RD=9.2%). However, this question was not applicable to the majority of those without MH conditions, where only around one in 10 of this group (n=19,541) indicated that they had MH needs at the last appointment. Moreover, this dimension of care was the lowest scoring, with over one-quarter of people with MH needs at their primary care appointment not having those needs met.
When responses were separated by ethnicity, the differences in care experiences associated with MH conditions were amplified for Māori (Table 3). The pattern of worse experiences of care among Māori and non-Māori with MH conditions compared with those without held across all measures (with the exception of meeting MH needs). Risk differences between those with and without MH conditions were consistently smaller for non-Māori than for Māori. For age and gender, there was a similar overall pattern of respondents with MH conditions reporting more negative experiences of primary care within all gender and age strata (Appendix Tables 1 and 2).
A high proportion of all survey respondents reported that they felt listened to, treated with respect and involved in decisions (e.g., >90% reported definitely being treated with respect). People with self-reported MH conditions attending general practice in Aotearoa New Zealand report predominantly positive experiences in primary healthcare, and three-quarters report having their MH needs “definitely” met. However, a clear and consistent pattern of worse experiences of primary healthcare compared with those without MH conditions is evident. This same pattern holds across breakdowns by gender and age group, and across all dimensions of experience for Māori and non-Māori respondents.
Other recent research on the healthcare experiences of people in Aotearoa New Zealand with MH and substance use conditions was conducted in 2022 using a web-based survey of adults.6 Participants were recruited nationally through MH, addiction and lived experience networks and social media. In a subset of respondents who had accessed primary care services (n=335), the majority reported positive experiences; for example, always or most of the time being treated with respect (81%) and being listened to (79%). However, non-Māori had better experiences than Māori for both of these measures. The lower proportion of positive responses in that study compared with the PCPES reported here may relate to the survey sample. This was self-selected, which could introduce bias if people responded more to the survey if they had negative experiences to report and included a high proportion (more than 20%) of people with schizophrenia or bipolar disorder diagnoses, who experience more discrimination than people with other MH conditions. In addition, the majority (70%) were under 45 years of age and younger age in general is associated with responses that are not as positive as those from older people. The differences may also relate to respondents being asked about experiences over the last 5 years, and from all primary care staff. In comparison, the PCPES asks about reception or administrative staff separately and the results presented here concentrate on experiences of clinical interactions at the most recent visit. Another survey of people in Auckland who were engaged with MH services14 found that people with MH conditions were much more likely to be unable to access a GP within 24 hours, compared with the general population.
Similar findings have also been found in research from Australia into physical healthcare service access for people with MH conditions.15 This Australian study found that people with MH conditions, compared with those without MH conditions, reported lower levels of being treated with respect, higher levels of waiting for an appointment, not having a response from a GP clinic, not being involved in decisions and the GP not spending enough time.
The importance of strong therapeutic relationships with primary healthcare practitioners for people with MH conditions has long been acknowledged.16 Positive relationships (characterised as empathetic, non-judgmental and person centred) facilitate access to services, while experiences of stigma or a lack of knowledge from providers act as a barrier.17 Patient-centred approaches to care and a focus on empathy in communication styles have been central to primary care clinician training and practice for many years, and no doubt are contributing to the high levels of positive patient experiences reported.18 However, stigmatised attitudes towards people with MH conditions are common in primary care providers, even more than in the general population.19,20 Discrimination from health professionals also contributes to diagnostic overshadowing, where physical conditions in people with MH conditions are missed or under-treated.21 People who experience stigma and discrimination are more likely to report unmet health needs, poor communication from providers and difficulties in accessing healthcare.22 Healthcare experience is a modifiable factor that can improve health outcomes for people experiencing MH conditions. The results presented in this analysis, consistent with research conducted previously, emphasise the need to ensure that all primary health practitioners are skilled and comfortable with supporting people with MH conditions. A patient-centred approach, with a focus on empathy in communicating with patients, has the potential to both improve clinical outcomes and patient satisfaction with services.23,24 Programmes to address stigma and discrimination in health professionals need to take a tailored and multifaceted approach, recognising that the origins and impacts of stigma and discrimination can differ across organisations and individuals.25 The potential to reduce stigma and discrimination towards people with MH conditions goes hand-in-hand with improving both experiences of care and health outcomes.26
Relatively little research has been done on the intersection of MH discrimination and racism, but these factors can compound to cause negative impacts on patient–doctor relationships and quality of care,8,27 and there is plenty of evidence that racism is a determinant of health in Aotearoa New Zealand.28,29 Interventions tailored to the Aotearoa New Zealand context and workforce that address this intersection are urgently required, as well as equity targets to ensure that progress in addressing systemic racism is monitored and change is achieved.
This study used a large sample of people accessing primary care in Aotearoa New Zealand, where self-reported information on MH conditions was available for almost every participant. The PCPES is one of the main measures of patient experience of care in Aotearoa New Zealand and uses validated measures on patient care experiences. Although the response rate is relatively low, this is comparable to similar surveys and a strong survey methodology and representative sampling mean that the risk of non-response bias is low.30 However, it only captures people who have accessed primary care, and people with MH conditions may not seek healthcare due to fear or past experiences of discrimination.20,31 The data collection period occurred during the COVID-19 pandemic, which could have affected patient experiences. However, it is notable that predominantly positive experiences were reported.
The focus of this study was on comparing those with and without MH conditions within the responding sample, and so while survey weights were used in the calculations (typically serving to weight responses to be representative of the population accessing primary care), the presented results as proportions and risk differences have been age/gender-standardised to the profile of the group with a history of MH conditions in order to adjust for confounding by these factors. This maximises internal validity for comparing these groups, but means that the proportions of responses are not directly comparable to other survey analyses using weighted data.
The data available allowed us to identify people with MH conditions. However, it was not possible to explore history of MH conditions in more detail than the diagnoses of anxiety and depression and an “other” category. It was therefore not possible to explore whether there were different impacts on care experiences for people diagnosed with different types of condition; for example, psychosis versus mood disorders. Previous research has indicated that people with substance use conditions experience stigma impacting on quality of care provided.32,33 In this survey, data on substance use conditions were not collected and so it was also not possible to explore the impact of substance use conditions on care experiences. The group identified as having MH conditions lasting longer than 6 months will include those with conditions having a higher impact, who are likely to be accessing specialist MH services, as well as those whose conditions are managed in primary care.
We have focussed on comparing the reported experiences of Māori as the Indigenous population compared with non-Māori. However, we recognise that the non-Māori group will include other ethnic groups that experience discrimination and marginalisation, including Pacific peoples. This will mean that the true of extent of inequities between Māori and NZ European, as the most privileged group, may be masked in this comparison.
From a public health and equity perspective, our findings demonstrate the importance of thinking carefully about the populations we compare when monitoring patient experience and outcomes. Adopting an approach that considers healthcare equity for people with MH conditions will support improved understanding of how experience of care may impact on outcomes for people experiencing long-term mental distress and contribute to improving experiences of care.
Within this, inequalities in the receipt of quality physical healthcare may be intensified among those who experience MH conditions and are also members of other minoritised or marginalised groups. Our results demonstrate that for Māori, poor experiences of healthcare are compounded among people with MH conditions.
This analysis adds to the increasing body of evidence that experience of MH conditions is associated with adverse healthcare experiences. It demonstrates that data are available in Aotearoa New Zealand to routinely monitor and report on care experiences for this group. Interventions to improve healthcare to provide equitable care for Māori with MH conditions are required as a priority. Further research should focus on developing and evaluating the effectiveness of interventions in the Aotearoa New Zealand context.
View Appendix.
The study explored whether the reported experience of primary healthcare differs for survey respondents in Aotearoa New Zealand who self-report having a mental health (MH) condition in comparison with those who do not.
Responses to the New Zealand Health Quality & Safety Commission’s adult primary care patient experience survey received from August 2020 to May 2022 were analysed. Comparative analysis of patient-reported experience measures were completed to contrast experiences reported by those with and without a MH condition, with results stratified by ethnicity (Māori/non-Māori), age group and gender. Age/gender-standardised estimates for proportions of positive responses to each question were developed for each group alongside standardised risk differences.
Our sample comprised 201,650 responses, with 21% reporting a current diagnosed MH condition. While most respondents reported positive experiences of primary healthcare, we found a consistent pattern of fewer positive experiences for those with MH conditions across dimensions of care quality, age and gender groups. When responses were separated by ethnicity, this difference was amplified among Māori.
This analysis adds to the increasing body of evidence that experience of MH conditions is associated with worse healthcare experiences. It demonstrates that data are available in Aotearoa New Zealand to routinely monitor and report on primary care experiences for this group. Interventions to improve healthcare should focus on care for Māori with MH conditions as a priority.
Ruth Cunningham: Research Associate Professor and Public Health Physician, Department of Public Health, University of Otago, Wellington, New Zealand.
Julie Artus: Research Associate, Department of Psychological Medicine, University of Otago, Wellington, New Zealand.
Fiona Imlach: Senior Research Fellow, Department of Public Health, University of Otago, Wellington, New Zealand.
James Stanley: Research Professor and Biostatistician, Department of Public Health, University of Otago, Wellington, New Zealand.
Tracy Haitana: Senior Lecturer, Department of Māori and Indigenous Health Innovation, University of Otago, Christchurch, New Zealand.
Helen Lockett: Honorary Senior Research Fellow, Department of Public Health, University of Otago, Wellington, New Zealand.
Debbie Peterson: Honorary Senior Research Fellow, Department of Public Health, University of Otago, Wellington, New Zealand.
Catherine Gerard: Assistant Director, Health Quality Intelligence, Health Quality & Safety Commission, Wellington, New Zealand.
Health Quality & Safety Commission (HQSC) for providing the data and supporting this analysis (grant #20-216). Nicholas Ye, who conducted the initial analyses for this paper as a summer student in the Department of Public Health.
Ruth Cunningham: Department of Public Health, University of Otago, PO Box 7343, Wellington 6242.
Nil.
1) Scott KM, Lim C, Al-Hamzawi A, et al. Association of Mental Disorders with Subsequent Chronic Physical Conditions: World Mental Health Surveys From 17 Countries. JAMA Psychiatry. 2016;73(2):150-58. doi: 10.1001/jamapsychiatry.2015.2688.
2) Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry. 2015;72(4):334-41. doi: 10.1001/jamapsychiatry.2014.2502. Erratum in: JAMA Psychiatry. 2015 Jul;72(7):736. doi: 10.1001/jamapsychiatry.2015.0937. Erratum in: JAMA Psychiatry. 2015 Dec;72(12):1259. doi: 10.1001/jamapsychiatry.2015.2246.
3) Richmond-Rakerd LS, D’Souza S, Milne BJ, et al. Longitudinal Associations of Mental Disorders With Physical Diseases and Mortality Among 2.3 Million New Zealand Citizens. JAMA Netw Open. 2021;4(1):e2033448. doi: 10.1001/jamanetworkopen.2020.33448.
4) Firth J, Siddiqi N, Koyanagi A, et al. The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. Lancet Psychiatry. 2019;6(8):675-712. doi: 10.1016/S2215-0366(19)30132-4.
5) Doyle C, Lennox L, Bell D. A systematic review of evidence on the links between patient experience and clinical safety and effectiveness. BMJ Open. 2013;3(1):e001570. doi: 10.1136/bmjopen-2012-001570.
6) Cunningham R, Imlach F, Lockett H, et al. Do patients with mental health and substance use conditions experience discrimination and diagnostic overshadowing in primary care in Aotearoa New Zealand? Results from a national online survey. J Prim Health Care. 2023 Jun;15(2):112-121. doi: 10.1071/HC23015.
7) Jacobs R, Aylott L, Dare C, et al. The association between primary care quality and healthcare use, costs and outcomes for people with serious mental illness: a retrospective observational study. Southampton (UK): NIHR Journals Library; 2020 Jun.
8) Cabassa LJ, Gomes AP, Meyreles Q, et al. Primary health care experiences of Hispanics with serious mental illness: a mixed-methods study. Adm Policy Ment Health. 2014;41(6):724-36. doi: 10.1007/s10488-013-0524-2.
9) Pitrou I, Berbiche D, Vasiliadis HM. Mental health and satisfaction with primary care services in older adults: a study from the patient perspective on four dimensions of care. Fam Pract. 2020;37(4):459-64. doi: 10.1093/fampra/cmaa019.
10) Batbaatar E, Dorjdagva J, Luvsannyam A, et al. Determinants of patient satisfaction: a systematic review. Perspect Public Health. 2017;137(2):89-101. doi: 10.1177/1757913916634136.
11) Health Quality & Safety Commission. Patient experience survey – adult primary care: Methodology and procedures [Internet]. Wellington, New Zealand: Health Quality & Safety Commission; 2020 [cited 2024 Aug 12]. Available from: https://www.hqsc.govt.nz/assets/Our-data/Publications-resources/PCPES_methodology_and_procedures_Aug2020.pdf
12) Association of Public Health Epidemiologists in Ontario. Methods for Age Standardizing Survey Estimates [Internet]. 2018 [cited 2024 Feb 22]. Available from: https://www.apheo.ca/methods-for-age-standardizing-survey-estimates
13) Higgins JPT, Li T, Deeks JJ. Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins J, Thomas J, editors. Cochrane Handbook for Systematic Reviews of Interventions Cochrane; 2019. p. 143-76.
14) Wheeler A, McKenna B, Madell D. Access to general health care services by a New Zealand population with serious mental illness. J Prim Health Care. 2014;6(1):7-16.
15) Corscadden L, Callander EJ, Topp SM. Disparities in access to health care in Australia for people with mental health conditions. Aust Health Rev. 2019;43(6):619-27. doi: 10.1071/AH17259.
16) Light E, Kerridge I, Robertson M, et al. Involuntary psychiatric treatment in the community: general practitioners and the implementation of community treatment orders. Aust Fam Physician. 2015;44(7):485-89.
17) Sturman N, Williams R, Ostini R, et al. ‘A really good GP’: Engagement and satisfaction with general practice care of people with severe and persistent mental illness. Aust J Gen Pract. 2020;49(1-2):61-65. doi: 10.31128/AJGP-02-19-4854.
18) The Royal New Zealand College of General Practitioners. Fellowship Assessment: Standards and guidelines for candidates [Internet]. Wellington, New Zealand: Royal New Zealand College of General Practitioners; 2023 [cited 2024 Aug 12]. Available from: https://www.rnzcgp.org.nz/study-with-us/study-general-practice/policies-and-regulations/
19) Vistorte AOR, Ribeiro WS, Jaen D, et al. Stigmatizing attitudes of primary care professionals towards people with mental disorders: A systematic review. Int J Psychiatry Med. 2018;53(4):317-38. doi: 10.1177/0091217418778620.
20) Tyerman J, Patovirta AL, Celestini A. How Stigma and Discrimination Influences Nursing Care of persons Diagnosed with Mental Illness: A Systematic Review. Issues Ment Health Nurs. 2021;42(2):153-63. doi: 10.1080/01612840.2020.1789788.
21) Nash M. Diagnostic overshadowing: A potential barrier to physical health care for mental health service users. Mental Health Practice. 2013;17(4):22-26. doi:10.7748/mhp2013.12.17.4.22.e862.
22) Royal Kenton N, Broffman L, Jones K, et al. Patient experiences in behavioral health integrated primary care settings: the role of stigma in shaping patient outcomes over time. Psychol Health Med. 2019;24(10):1182-97. doi: 10.1080/13548506.2019.1595685.
23) Derksen F, Bensing J, Lagro-Janssen A. Effectiveness of empathy in general practice: a systematic review. Br J Gen Pract. 2013;63(606):e76-84. doi: 10.3399/bjgp13X660814.
24) Brickley B, Sladdin I, Williams LT, et al. A new model of patient-centred care for general practitioners: results of an integrative review. Fam Pract. 2020;37(2):154-72. doi: 10.1093/fampra/cmz063.
25) Ungar T, Knaak S, Szeto AC. Theoretical and Practical Considerations for Combating Mental Illness Stigma in Health Care. Community Ment Health J. 2016;52(3):262-71. doi: 10.1007/s10597-015-9910-4.
26) Knaak S, Modgill G, Patten SB. Key ingredients of anti-stigma programs for health care providers: a data synthesis of evaluative studies. Can J Psychiatry. 2014;59(10 Suppl 1):S19-26. doi: 10.1177/070674371405901s06.
27) Das-Munshi J, Stewart R, Morgan C, et al. Reviving the ‘double jeopardy’ hypothesis: physical health inequalities, ethnicity and severe mental illness. Br J Psychiatry. 2016;209(3):183-85. doi: 10.1192/bjp.bp.114.159210.
28) Harris R, Cormack D, Waa A, et al. The impact of racism on subsequent healthcare use and experiences for adult New Zealanders: a prospective cohort study. BMC Public Health. 2024;24(1):136. doi: 10.1186/s12889-023-17603-6.
29) Reid P, Cormack D, Paine SJ. Colonial histories, racism and health-The experience of Māori and Indigenous peoples. Public Health. 2019;172:119-24. doi: 10.1016/j.puhe.2019.03.027.
30) Gerard C, O'Brien I, Shuker C, et al. Patient experience surveys are vital in the twenty-first century: let’s put some myths to rest. N Z Med J. 2024;137(1588):80-9. doi: 10.26635/6965.6320.
31) Thornicroft G. Stigma and discrimination limit access to mental health care. Epidemiol Psychiatr Soc. 2008;17(1):14-19. doi: 10.1017/s1121189x00002621.
32) van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1-2):23-35. doi: 10.1016/j.drugalcdep.2013.02.018.
33) Farrugia A, Pienaar K, Fraser S, et al. Basic care as exceptional care: addiction stigma and consumer accounts of quality healthcare in Australia. Health Sociol Rev. 2021;30(2):95-110. doi: 10.1080/14461242.2020.1789485.
Sign in to view your account and access
the latest publications by the NZMJ.
Don't have an account?
Let's get started with creating an account.
Already have an account?
Become a member to enjoy unlimited digital access and support the ongoing publication of the New Zealand Medical Journal.
The New Zealand Medical Journal is fully available to individual subscribers and does not incur a subscription fee. This applies to both New Zealand and international subscribers. Institutions are encouraged to subscribe. The value of institutional subscriptions is essential to the NZMJ, as supporting a reputable medical journal demonstrates an institution’s commitment to academic excellence and professional development. By continuing to pay for a subscription, institutions signal their support for valuable medical research and contribute to the journal's continued success.
Please email us at nzmj@pmagroup.co.nz